These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27710241)

  • 1. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
    Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
    Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M; Norjavaara E; Dunkel L
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature.
    Krebs A; Moske-Eick O; Doerfer J; Roemer-Pergher C; van der Werf-Grohmann N; Schwab KO
    J Pediatr Endocrinol Metab; 2012; 25(5-6):581-5. PubMed ID: 22876562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
    Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
    Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height Increment and Laboratory Profile of Boys Treated With Aromatase Inhibitors With or Without Growth Hormone.
    Pedrosa LF; de Oliveira JM; Thomé PRV; Kochi C; Damiani D; Longui CA
    Horm Metab Res; 2017 Oct; 49(10):778-785. PubMed ID: 28859208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study.
    Ma Y; Jia R; Xia B; Tang B; Xu Z
    BMC Pediatr; 2022 Jun; 22(1):371. PubMed ID: 35764954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
    Mauras N; Welch S; Rini A; Klein KO
    J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1597-606. PubMed ID: 15645693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M; Wickman S; Dunkel L
    Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors.
    Bullinger M; Bloemeke J; Mericq V; Sommer R; Gaete X; Ross JL; Yu YM; Permuy J; Gagliardi P; Damaso YL; Mauras N
    Horm Res Paediatr; 2018; 90(6):381-392. PubMed ID: 30820008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty].
    Zhao X; Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):397-400. PubMed ID: 24750838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M; Momoi T; Yorifuji T; Muroi J; Yamanaka C; Sasaki H; Furusho K
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.